SJS Investment Consulting’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.3K Buy
65
+29
+81% +$12.2K ﹤0.01% 637
2026
Q1
$13.6K Buy
36
+27
+300% +$11.6K ﹤0.01% 761
2025
Q4
$3.85K Buy
9
+8
+800% +$3.48K ﹤0.01% 1004
2025
Q3
$448 Sell
1
-1
-50% -$453 ﹤0.01% 1267
2025
Q2
$974 Sell
2
-1
-33% -$570 ﹤0.01% 863
2025
Q1
$1.85K Hold
3
﹤0.01% 759
2024
Q4
$1.59K Sell
3
-1
-25% -$564 ﹤0.01% 820
2024
Q3
$2.4K Hold
4
﹤0.01% 711
2024
Q2
$2.17K Hold
4
﹤0.01% 675
2024
Q1
$2.57K Hold
4
﹤0.01% 645
2023
Q4
$2.34K Hold
4
﹤0.01% 602
2023
Q3
$2.08K Hold
4
﹤0.01% 622
2023
Q2
$2.17K Sell
4
-1
-20% -$547 ﹤0.01% 576
2023
Q1
$2.69K Sell
5
-1
-17% -$510 ﹤0.01% 515
2022
Q4
$3.06K Buy
6
+3
+100% +$1.46K ﹤0.01% 470
2022
Q3
$1K Buy
+3
New +$1.44K ﹤0.01% 654
2022
Q1
$1K Buy
+1
New +$480 ﹤0.01% 557

Other funds holding CHE

SJS Investment Consulting's CHE Position: Q2 2026 in Review

SJS Investment Consulting increased its Chemed (CHE) stake by 81% in Q2 2026, buying an estimated $12.2K and bringing the position to 65 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

SJS Investment Consulting first reported a position in CHE in Q1 2022 and has held it in 17 quarters since. 262 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • SJS Investment Consulting held 65 shares of Chemed worth $30.3K as of Q2 2026.
  • SJS Investment Consulting bought 29 Chemed shares in Q2 2026, an estimated $12.2K.
  • Chemed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #637 holding.
  • SJS Investment Consulting first reported a position in Chemed in Q1 2022 and has held it in 17 quarters since.
  • 262 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.